Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idrabiotaparinux versus warfarin for prevention of stroke and systemic embolism in atrial fibrillation
2007-004817-33Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Idrabiotaparinux with Warfarin (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2007; status: terminated.
02
Drugs
idrabiotaparinuxwarfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-004817-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004817-33.